All the major players have 2mm femoral sizing, assymetrical tibial components, new gen instruments, and "Epoly". I enjoy the line "And, of course, Epoly is so much better too.", like there is long-term clinical data showing this (yes, vitamin E looks great in lab tests).
I agree with some of the above posters, its not the daily grind anymore that sells these implants and moves market share. If you are a surgeon that does 3-4 or more joints per week, you are tied to your company/rep somehow, and most likely for good unless a better offer becomes available from an upstart knee company or POD situation. I can spend thousands of dollars a month on lunches, demos, dinners, meetings, inservices....and unless my company is "on board" then I am ultimately wasting my time. Maybe this is just my market, but the old surgeons have been locked into their implant for 10-15 years, and new surgeons go with whoever makes them a consultant first.